- Home
- PBYI vs LCNB Comparison
PBYI vs LCNB Comparison
Compare PBYI & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- LCNB
- Stock Information
- Founded
- PBYI 2010
- LCNB 1877
- Country
- PBYI United States
- LCNB United States
- Employees
- PBYI N/A
- LCNB N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- LCNB Major Banks
- Sector
- PBYI Health Care
- LCNB Finance
- Exchange
- PBYI Nasdaq
- LCNB Nasdaq
- Market Cap
- PBYI 171.7M
- LCNB 205.5M
- IPO Year
- PBYI N/A
- LCNB N/A
- Fundamental
- Price
- PBYI $4.64
- LCNB $15.93
- Analyst Decision
- PBYI Strong Buy
- LCNB
- Analyst Count
- PBYI 1
- LCNB 0
- Target Price
- PBYI $7.00
- LCNB N/A
- AVG Volume (30 Days)
- PBYI 648.1K
- LCNB 16.5K
- Earning Date
- PBYI 11-06-2025
- LCNB 10-20-2025
- Dividend Yield
- PBYI N/A
- LCNB 5.55%
- EPS Growth
- PBYI 434.29
- LCNB 186.06
- EPS
- PBYI 0.97
- LCNB 1.49
- Revenue
- PBYI $238,062,000.00
- LCNB $86,864,000.00
- Revenue This Year
- PBYI N/A
- LCNB $0.86
- Revenue Next Year
- PBYI N/A
- LCNB $5.93
- P/E Ratio
- PBYI $4.76
- LCNB $10.64
- Revenue Growth
- PBYI 8.63
- LCNB 22.73
- 52 Week Low
- PBYI $2.32
- LCNB $13.34
- 52 Week High
- PBYI $6.07
- LCNB $17.92
- Technical
- Relative Strength Index (RSI)
- PBYI 49.99
- LCNB 54.11
- Support Level
- PBYI $4.49
- LCNB $15.75
- Resistance Level
- PBYI $5.22
- LCNB $16.34
- Average True Range (ATR)
- PBYI 0.26
- LCNB 0.32
- MACD
- PBYI -0.12
- LCNB -0.02
- Stochastic Oscillator
- PBYI 22.33
- LCNB 54.21
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.